v3.26.1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Deferred Shares
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2024   50,064,860 5,793,501      
Beginning balance at Dec. 31, 2024 $ 360,716 $ 135 $ 1 $ 1,190,104 $ (795,761) $ (33,763)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 5,023       5,023  
Other comprehensive (loss) income 673         673
Exercised of share options (in shares)   119,749        
Exercise of share options 2,551     2,551    
Share-based compensation expense 9,516     9,516    
Ending balance (in shares) at Mar. 31, 2025   50,184,609 5,793,501      
Ending balance at Mar. 31, 2025 $ 378,479 $ 135 $ 1 1,202,171 (790,738) (33,090)
Beginning balance (in shares) at Dec. 31, 2025 50,689,271 50,689,271 5,793,501      
Beginning balance at Dec. 31, 2025 $ 381,033 $ 136 $ 1 1,240,255 (831,275) (28,084)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 12,971       12,971  
Other comprehensive (loss) income (7,289)         (7,289)
Equity plan options exercised and units assigned (in shares)   142,657        
Equity plan options exercised and units assigned $ 656 $ 1   655    
Exercised of share options (in shares) 27,334          
Share-based compensation expense $ 6,302     6,302    
Ending balance (in shares) at Mar. 31, 2026 50,831,928 50,831,928 5,793,501      
Ending balance at Mar. 31, 2026 $ 393,673 $ 137 $ 1 $ 1,247,212 $ (818,304) $ (35,373)